Your browser doesn't support javascript.
loading
Functional and mechanistic advantage of the use of a bifunctional anti-PD-L1/IL-15 superagonist.
Knudson, Karin M; Hicks, Kristin C; Ozawa, Yohei; Schlom, Jeffrey; Gameiro, Sofia R.
Afiliação
  • Knudson KM; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
  • Hicks KC; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
  • Ozawa Y; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
  • Schlom J; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA schlomj@mail.nih.gov.
  • Gameiro SR; Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
J Immunother Cancer ; 8(1)2020 04.
Article em En | MEDLINE | ID: mdl-32303618

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos / Interleucina-15 / Antígeno B7-H1 / Antineoplásicos Imunológicos / Neoplasias Mamárias Experimentais Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos / Interleucina-15 / Antígeno B7-H1 / Antineoplásicos Imunológicos / Neoplasias Mamárias Experimentais Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article